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Ann Arbor, Michigan, U.S.A. 
Ketamine causes cardiovascular stimulation, presumably, by increasing central 
sympathetic activity. This study was undertaken to find out if diazepam in 
appropriate doses could abolish or moderate the central sympathetic and cardio- 
vascular stimulation following ketamine in patients undergoing cardiac surgery. 
Twelve patients, scheduled for valvular replacement (8) and direct aorto- 
coronary bypass graft operations (4) were studied. After premedication with 
diazepam 0.15 mg/kg orally and morphine sulphate 0.15 mg/kg i.m., they were 
induced with diazepam 0.3 mg/kg i.v., followed 10 rnin later by ketamine 2 mg/kg 
i.v. Direct arterial pressure by a strain gauge from the radial artery and heart rate 
by EKG were continuously recorded. Plasma free norepinephrine, measured by 
Vendsalu’s method, in the arterial blood was 0.39 k 0.03 ng/ml prior to induction, 
0.39 f 0.03 ng/ml 10 min after diazepam and 0.42 f 0.05 ng/ml (P> 0.05) 5 min 
after ketamine administration. Plasma free epinephrine concentrations were 
0.10+0.04 ng/ml prior to induction, 0.06&0.03 ng/ml (P>0.05) 10 rnin after 
diazepam and 0.01 k 0.003 ng/ml ( P <  0.05) 5 min after ketamine. Heart rate and 
systolic pressure did not change significantly throughout the study period. Diastolic 
pressures were elevated significantly ( P i  0.05) 5 min after ketamine administra- 
tion, amounting to a 12% increase over baseline. 
Diazepam-ketamine induction in cardiac surgical patients did not result in 
clinically significant central sympathetic or cardiovascular stimulation. 
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Ketamine has been recommended for anes- 
thesia in patients undergoing open-heart 
surgery (CORSSEN et al. 1970) and the criti- 
cally ill (CHASAPAKIS et al. 1973) because of 
its cardiovascular stimulant effects, resulting 
in increased heart rate, arterial blood pressure 
and cardiac output (VIRTUE et al. 1967, 
TWEED et al. 1972). The mechanism of the 
cardiovascular stimulation following keta- 
mine could be a direct effect of the drug on 
the heart and/or peripheral vasculature or it 
could be due to indirect action through 
alterations in the autonomic outflow. 
Direct myocardial stimulation by ketamine 
is unlikely because in dog heart-lung prepara- 
tions i t  acts as a myocardial depressant 
(TRABER et al. 1968). Furthermore, ketamine, 
when given in increasing doses (5-20 mg/kg) 
to dogs with a complete epidural block, 
causes progressive myocardial depression, 
hypotension and no change in heart rate 
(TRABER & WILSON 1969). This suggests that 
its cardiovascular effects in normal animals 
are probably due to central sympathetic 
stimulation. Further evidence to support the 
contention that ketamine produces central 
sympathetic stimulation is provided by the 
studies of ZSICMOND et al. (1974a) and 
IVANKOVICH et al. (1974). ZSICMOND et al. 
showed a significant increase in heart rate, 
arterial blood pressure and plasma free nor- 
epinephrine concentration following the ad- 
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ministration of ketamine in patients without 
cardiac disease, and IVANKOVICH et al. elicited 
circulatory stimulation by injecting ketamine 
directly into the vessels of the isolated cerebral 
hemispheres of goats in fractions of the doses 
used to elicit a similar response when it is 
injected into a peripheral vein. 
Cardiovascular stimulation following in- 
duction of anesthesia with ketamine alone is 
also accompanied by increased myocardial 
work and myocardial oxygen consumption. 
Hence, use of this technique in patients with 
ischemic heart disease may be inadvisable, 
and its use in patients with any cardiac 
disease requires great caution (TWEED et al. 
1972). 
Several drugs have been shown either to 
moderate or to abolish the cardiovascular 
stimulation observed following ketamine; 
these include: hexamethonium (TRABER et 
al. 1970a), atropine (TRABER et al. 1970b), 
phentolamine (TRABER et al. 1971), pento- 
barbital (IVANKOVICH et al. 1974), halothane 
(STANLEY 1973), droperidol (DUNDEE et al. 
1971) and diazepam (ZSIGMOND et al. 197413). 
We used diazepam prior to induction of 
anesthesia with ketamine for several reasons. 
In  low doses (0.1 mg/kg i.v.) diazepam does 
not cause a significant change in heart rate, 
systemic arterial pressure, cardiac output or 
right ventricular dp/dt (DALEN et al. 1969, 
IKRAM & RUBIN 1971). Furthermore, in a 
similar dose, it has been shown to decrease 
significantly left ventricular end-diastolic 
pressure, tension-time index and myocardial 
oxygen consumption in patients with normal 
and diseased coronary arteries (COTE et al. 
1974). In  yet another study (IKRAM et al. 
1973), diazepam (0.1 mg/kg i.v.) was shown 
to increase myocardial blood flow signifi- 
cantly in patients with both normal and 
diseased coronary arteries (the increase being 
more pronounced in the latter group). At 
higher dose levels (0.7-0.8 mg/kg i.v.), how- 
ever, diazepam has been shown to increase 
heart rate, and to decrease significantly 
systolic and diastolic pressures, cardiac out- 
put, stroke volume and left ventricular stroke 
work, while total peripheral resistance did 
not change (KAO et al. 1973). Although 
hemodynamic changes following the diaze- 
pam dose (0.15 mg/kg orally plus 0.3 mg/kg 
i.v. 1 h later) proposed for the present study 
have not been reported to our knowledge, 
they may be expected to be between the 
range of changes cited above. 
This study was undertaken, therefore, to 
investigate whether ketamine in combination 
with diazepam, in the proposed doses, could 
be used for induction of anesthesia in cardiac 
surgical patients without causing excessive 
central sympathetic and cardiovascular 
stimulation, as reflected by changes in heart 
rate and arterial blood pressures and in 
plasma free norepinephrine (NE) and epi- 
nephrine (E) concentrations. 
MATERIALS AND METHODS 
Twelve patients who were scheduled for elective open- 
heart surgery for valvular replacement (eight) and 
direct aorto-coronary saphenous vein bypass graft 
operations (four) were studied. Their physical charac- 
teristics are shown in Table 1. They had not received 
propranolol for 2 weeks prior to surgery. Their mean 
age was 53 years (range 29-65 years), mean weight 
67 kg (range 40-95 kg) and mean height 166 cm (range 
150-182 cm). All patients had an ASA physical status 
classification of 3 or 4. 
Preanesthetic medication consisted of 0.15 mg/kg 
diazepam orally and 0.15 mg/kg morphine sulphate 
ism., given 1 h before the patient was brought to the 
operating room. Atropine was not used in the premrdi- 
cation and/or prior to completion of the study. There 
was a period of 5 to 10 min between the insertion of 
intravenous and arterial catheters and the first baseline 
arterial blood sampling. No skin preparation, positional 
changes or instrumentation, other than the preceding 
(e.g. bladder catheterization, CVP catheter inscrtion), 
were allowed before and/or during the study. 
Anesthesia was induced with 0.3 mg/kg diazepam 
given into a peripheral intravenous line during a 
2-minute period, while the patient breathed 100% 
oxygen. Ten minutes after diazepam, 2 mg/kg ketamine 
hydrochloride was given into a peripheral intravenous 
line over a 1-minute period. Ventilation was assisted as 
required throughout the stuciy in order to maintain 
arterial Pco, between 35 and 45 mmHg (4.6 and 6.0 
kPa). Arterial blood samples for blood-gas analysis and 
determination of plasma free norepinephrine and cpi- 
nephrine concentrations were drawn prior to induction, 
10 min after completion of the diazepam injection and 
5 min after completion of ketamine administration. 
A Radiometer (Copenhagen) blood gas analyeer 
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Table 1 
Physical characteristics of the patients. 
1 55.0 F 165.0 62.0 AS 
2 60.0 F 150.0 46.0 AS, AI, MS, M I  
3 55.0 M 170.0 58.0 MI, TI 
4 29.0 F 155.0 50.0 MS, TI 
5 42.0 M 170.0 77.0 CAD, Angina pectoris 
6 53.0 M 177.0 95.0 CAD, Angina pectoris 
7 54.0 M 182.0 95.0 CAD, Angina pectoris 
8 52.0 F 172.0 60.0 MI 
9 63.0 F 157.0 40.0 A1 
10 58.0 M 162.0 82.0 CAD, Angina pectoris 
11 45.0 M 165.0 82 .O AS 
12 65.0 M 165.0 55.0 MI 
N =  12 M = 7, 
Mean 53.0 F = 5  166.0 67.0 
* AS = Aortic stenosis; A1 = Aortic incompetence; MS = Mitral stenosis; MI = Mitral incom- 
petence; TI = Tricuspid incompetence; CAD = Coronary artery disease. 
was used for arterial blood-gas analysis; the plasma 
free norepinephrine and epinephrine concentrations 
were determined in duplicate by VENDSALU’S method 
(1960), as modified by KELSCH et al. (1971). Labora- 
tory personnel were not aware of the time of sampling, 
the sequence of samples or the nature of the study. 
Arterial blood pressure was recorded on a Hewlett 
Packard multichannel recorder, via a Hewlett Packard 
strain gauge connected to an indwelling catheter in the 
radial artery. ECG lead 11, or the lead giving the 
tallest R-wave, was continuously recorded and utilized 
in the calculation of heart rate at  the time of sampling. 
Student’s t-test for paired data was used for statistical 
analysis; a P-value of <0.05 was considered to be 
statistically significant. The values in the text are 
means f see. mean, unless otherwise indicated. 
RESULTS 
( 1 ) Plasma free norepinephrine and epinephrine 
No significant increase in mean plasma free 
norepinephrine concentration was observed 
following diazepam and after ketamine, as 
compared to baseline in the 12 patients 
(Table 2).  However, mean plasma free 
epinephrine concentration decreased signi- 
ficantly following ketamine (as seen in 
Table 2). 
( 2 )  Heart rate 
No significant change in mean heart rates 
was observed following diazepam and after 
ketamine, as compared to baseline (Table 3). 
(3) Direct arterial pressures 
Mean systolic pressure readings did not show 
any significant change from baseline values 
following diazepam and after ketamine. Mean 
diastolic pressure did not change significantly 
following diazepam, but was elevated 5 min 
after ketamine (P<0.05), as seen in Table 3. 
The increase in mean diastolic pressure 
following ketamine was 12 % over the baseline 
value. 
Patient #6 received sodium nitroprusside 
by intravenous infusion after the ketamine 
injection, while patient #lo received a 
sodium nitroprusside infusion which was 
started even before diazepam administration, 
since systolic blood pressure exceeding 180 
mmHg (23.9 kPa) in these patients was con- 
sidered unacceptable by the cardiac surgical- 
anesthesia team. Both these patients were 
scheduled to undergo aorto-coronary bypass 
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Table 2 
Plasma free norepinephrine and epinephrine concentrations following diazepam-ketamine induction 
in cardiac surgical patients. 
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Mean 0.39 0.39 0.42 0.10 0.06 0.006 
s.e. mean 0.03 0.03 0.05 0.04 0.03 0.003 
P-value 50.5 > 0.05 < 0.05 
* Patient received intravenous Na nitroprusside infusion soon after ketamine administration. 
t Patient received intravenous Na nitroprusside infusion throughout the study. 
operations. An exception was made in 
patient #9 who had chronic hypertensive 
cardiovascular disease, and whose systolic 
pressure was 200 mmHg (26.6 kPa) through- 
out the study. She did not receive sodium 
nitroprusside because her resting preopera- 
tive systolic pressure was between 180 and 200 
mmHg (23.9 and 26.6 kPa). 
(4) Arterial Blood Gases 
Arterial Po, was maintained at over 290 
mmHg in all patients during the study. Mean 
arterial Pco2 was 38.5k1.25 mmHg (5.12f 
0.17 kPa) prior to induction, 37.5 f 1.61 
mmHg (4.99f0.21 kPa) 10 min after 
diazepam and 37.5 & 2.17 mmHg (4.99 f 0.29 
kPa) 5 min after ketamine administration. 
(5) ECG 
No arrhythmias or ST, T-wave changes were 
noted in any of the patients during the study 
period. 
(6) Complications 
There was no evidence of any allergic re- 
action or other complications during the 
study period in any of the patients. 
DISCUSSION 
The absence of significant increases in heart 
rate and systolic arterial blood pressure, and 
a statistically significant though modest 
(12%) increase in diastolic pressure indicate 
that no marked increase in sympathetic tone 
was induced following the diazepam and 
ketamine induction sequence in this group of 
cardiac surgical patients. This is further con- 
firmed by a lack of significant increase in 
plasma free norepinephrine concentration 
following diazepam and ketamine and by a 
significant decrease in plasma iree epinephrine 
concentration following ketamine adminis- 
tration. Giving ketamine alone to a series of 
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sidered to be too hazardous and consequently 
ethically unacceptable, and was therefore not 
done. However, in an earlier study (ZSIGMOND 
et al. 1974a) in 12 patients without cardiac 
disease who were given ketamine 2 mg/kg 
intravenously, plasma free norepinephrine 
increased from a baseline value of 0.4*0.04 
ng/ml to 0.8f0.10 ng/ml (P<O.OOl); there 
was no significant change in plasma free 
epinephrine, which was undetectable in base- 
line samples and could be measured in only 
two patients 5 rnin after its administration. In  
these same 12 patients, heart rate and systolic 
arterial pressure were 70.6 f 7.4 beatslmin 
and 120.5k6.5 mmHg (16.0f0.86 kPa), 
respectively, before and 95.3 & 10.1 beats/min 
(P<0.05) and 146.5f7.8 mmHg (19.48f 
1.04 kPa) (P<O.Ol) 5 min after ketamine 
administration but prior to intubation. 
Arterial blood was selected for sampling 
for free norepinephrine and epinephrine 
levels because of the greater ease and rapidity 
of collection of large (20 ml) samples, as 
compared to peripheral venous samples. This 
is essential because the half-life of norepi- 
nephrine in plasma in uiuo is less than 2 min 
(WHITBY et al. 1961). Central venous cathe- 
terization prior to induction of anesthesia was 
considered too stressful. Since i t  has been 
shown that in anesthetized patients about 
25% of infused 'H-norepinephrine is removed 
in a single passage through the lungs (GILLIS 
et al. 1972), arterial levels of free norepi- 
nephrine in the present study are likely to be 
lower than they would have been in com- 
parable central venous samples. However, in 
our earlier studies (ZSIGMOND et al. 1974b), 
arteriovenous differences of plasma free nor- 
epinephrine determined in the radial artery 
and the contralateral antecubital vein did not 
change significantly following ketamine ad- 
ministration in patients. Although the base- 
line arterial plasma free norepinephrine level 
of 0.39k0.03 ng/ml in the present study 
group is significantly higher (P<O.Ol) than 
the resting plasma free norepinephrine level 
of 0.32f0.01 ng/ml in the arterial blood of 
34 noncardiac patients in the previous study 
(ZSIGMOND et al. 1974b), the difference can 
be explained, on the basis of a lower mean 
age (40 years) in the latter group, according 
to the equation described by LAKE et al. 
(1977). 
Decreased arterial plasma free epinephrine 
levels following ketamine may be due to a 
reduction in adrenomedullary activity ac- 
companying loss of consciousness and onset 
of anesthesia in the absence of sensory or 
chemical stimuli to the central nervous 
system. The clinical significance of this 
finding is doubtful, however, because in 6 out 
of the 12 patients in the study, plasma free 
epinephrine was undetectable throughout the 
study period. Similar inconsistency in plasma 
epinephrine levels has been reported follow- 
ing thiopental, cyclopropane, halothane and 
diethylether, and it has been suggested that 
adrenal medullae do not participate to any 
large extent in the sympathetic nervous 
response to anesthesia in man (PRICE et al. 
1959). 
The increase in diastolic pressure caused by 
ketamine may be due to a moderate increase 
in the central sympathetic activity not mani- 
fested by an  overflow in NE from receptor 
sites. However, it may also be due to a direct 
peripheral effect of ketamine on post-gangli- 
onic adrenergic neurons, where it has been 
shown to decrease the re-uptake of NE in rats 
(MILETICH et al. 1973), which in turn may 
cause peripheral vasoconstriction. 
Although the mean plasma free NE con- 
centration and mean systolic blood pressure 
for the whole group did not change signifi- 
cantly following diazepam or ketamine ad- 
ministration, this pattern was not consistently 
seen in individual patients. Thus no statisti- 
cally significant correlation was found be- 
tween systolic blood pressure and NE 
(correlation coefficient (CC) = -0.15) or 
E (CC: = 0.08), and between diastolic blood 
pressure and NE (CC = -0.37) or 1; 
(CC = 0.02) values as observed 5 min after 
ketamine administration. Similarly there was 
no statistically significant correlation between 
changes in systolic blood pressure 5 min after 
ketamine administration as compared to basc- 
line and similar changes in NE (<Xi = 
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-0.35) or E (CC = 0.47) concentrations, 
nor in changes in diastolic blood pressure 
5 min after ketamine administration as com- 
pared to baseline and similar changes in NE 
(CC = -0.26) and E (CC = 0.25) concen- 
trations. 
The lack of correlation between blood 
pressure and plasma free norepinephrine and 
epinephrine suggests that factors other than 
changes in sympathetic tone, as reflected by 
changes in plasma free norepinephrine and 
epinephrine, may be more important in 
determining the blood pressure a t  a given 
moment. Thus it has been suggested that 
vasomotor reactivity in patients with coronary 
artery disease is increased (HANSON et al. 
1976) ; therefore a given vasomotor stimulus 
may evoke an exaggerated hypertensive 
response in these patients and also the re- 
sponse may last for a longer time. A similar 
vascular hyperreactivity has also been sug- 
gested in patients with chronic essential 
hypertension (DOYLE & FRASER 1961). Also 
when adjusted for age, resting plasma free 
norepinephrine levels in patients with chronic 
essential hypertension have been shown to be 
comparable to a group of normotensive 
subjects (LAKE et al. 1977). Therefore the 
resting plasma NE concentrations may not 
necessarily be related to the resting blood 
pressure. 
However, it is also possible that changes in 
plasma free norepinephrine and epinephrine 
concentrations may not accurately represent 
corresponding changes in sympathetic tone, 
since they are governed by several other 
factors, including reuptake by adrenergic 
nerve endings, tissue uptake and metabolism. 
Within the context of the present study, how- 
ever, measurements of plasma free norepi- 
nephrine and epinephrine do show that pre- 
treatment with diazepam in the described 
dose can effectively prevent a rise in plasma 
free norepinephrine following ketamine ad- 
ministration. This indicates that a marked 
sympathetic stimulation does not occur when 
this Combination of drugs is used for induction 
of anesthesia. 
One of the major objections to the use of 
ketamine for induction of anesthesia in 
cardiac surgical patients has been its tendency 
to increase central sympathetic activity, lead- 
ing to marked cardiovascular stimulation. 
Addition of an adequate dose of diazepam 
prior to its administration can therefore 
reduce this stimulation sufficiently to make 
this combination quite useful in this group of 
patients. 
Another major objection to the use of 
ketamine in adults has been a high incidence 
of psychic side effects following its use 
(CORSSEN et al. 1968). Diazepam in the doses 
used in the present study has been shown to 
reduce significantly ( P <  0.001) the incidence 
of these reactions, a t  least in patients free of 
cardiovascular disease (KOTHARY & ZSIG- 
MOND 1976). Some of the other advantages of 
this combination of drugs are a lack of hypo- 
tension, cardiac arrhythmias and histamine 
release. 
The number of patients in this group is not 
large enough for valid statistical comparisons 
of the data for the patients with valvular 
disease vs. the group with coronary artery 
disease. However, the data presented here 
would suggest that a combination of diaze- 
pam and ketamine, when given according to 
the specified protocol, can induce anesthesia 
safely in patients undergoing cardiac valvular 
replacement or coronary artery bypass oper- 
ations. Further investigation in a larger 
patient population, particularly with regard 
to changes in various hemodynamic para- 
meters during this induction sequence, is 
needed before this technique can be recom- 
mended for widespread clinical use. 
In  conclusion, therefore, the combination 
of diazepam and ketamine, when used for 
induction of anesthesia in cardiac surgical 
patients according to the specified protocol, 
does not result in clinically significant central 
sympathetic stimulation or excessive cardio- 
vascular stimulation. 
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